Sutro Biopharma (STRO) Interest Coverage Ratio (QoQ) (2017 - 2025)
Sutro Biopharma (STRO) Interest Coverage Ratio (QoQ) (2017 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,526.67% |
| Jun 30, 2025 | 99.49% |
| Mar 31, 2025 | -4.99% |
| Dec 31, 2024 | -246.27% |
| Sep 30, 2024 | -39.51% |
| Jun 30, 2024 | 76.13% |
| Mar 31, 2024 | -108.84% |
| Dec 31, 2023 | 289.76% |
| Sep 30, 2023 | -12,787.73% |
| Jun 30, 2023 | 95.42% |
| Mar 31, 2023 | 86.98% |
| Dec 31, 2022 | -2,407.79% |
| Sep 30, 2022 | 76.45% |
| Jun 30, 2022 | 42.22% |
| Mar 31, 2022 | -411.78% |
| Dec 31, 2021 | 1,946.87% |
| Sep 30, 2021 | -241.30% |
| Jun 30, 2021 | 98.72% |
| Mar 31, 2021 | -1.22% |
| Dec 31, 2020 | -7,960.89% |